China Biologic Products (CBPO) Reports Q3 EPS of $0.96
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
China Biologic Reports Financial Results for the Third Quarter of 2018
November 1, 2018 4:30 PM EDT3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms;
Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms;
Net Income Up 4.1% YoY to $32.9 Million
Board of Directors Approves $100 Million Share Repurchase Program
BEIJING, Nov. 1, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading... More



